
RevolKa is a pioneer in next-generation protein engineering, utilizing its proprietary aiProtein® technology that integrates artificial intelligence with directed protein evolution. This innovative approach accelerates the development of novel proteins, enhancing their properties for therapeutic applications. The company focuses on research collaborations and co-development of its internal assets, positioning itself as a leader in biologics engineering. With a commitment to addressing challenges in the manufacturability and developability of therapeutic antibodies, RevolKa aims to optimize multiple protein characteristics simultaneously, establishing a strong market presence in the biopharmaceutical sector.

RevolKa is a pioneer in next-generation protein engineering, utilizing its proprietary aiProtein® technology that integrates artificial intelligence with directed protein evolution. This innovative approach accelerates the development of novel proteins, enhancing their properties for therapeutic applications. The company focuses on research collaborations and co-development of its internal assets, positioning itself as a leader in biologics engineering. With a commitment to addressing challenges in the manufacturability and developability of therapeutic antibodies, RevolKa aims to optimize multiple protein characteristics simultaneously, establishing a strong market presence in the biopharmaceutical sector.